Search contract descriptions, companies and agencies.
COVID-19. TO DEVELOP AND MANUFACTURE AN INACTIVATED VIRUS VACCINE USING BLOOD PATHOGEN REDUCTION TECHNOLOGY.
Total Committed
$3.1M
Product or Service Description
Physical Science Applied Research/Exploratory Development R&D
Total Potential Value
$18.6M
Contracting Agency
Effective Date
Sept. 1, 2020
Funding Department
NATIONAL INSTITUTES OF HEALTH NIAID
Type
Cost no fee
Solicitation Procedure
Negotiated proposal/quote
Extent Competed
Full and open competition
Recent Contract Actions 
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Vendor | Description | Signed | Reason for Change | Amount Committed |
|---|---|---|---|---|
| COLORADO STATE UNIVERSITY | COVID-19. TO DEVELOP AND MANUFACTURE AN INACTIVATED VIRUS VACCINE USING BLOOD PATHOGEN REDUCTION TECHNOLOGY. | Aug. 21, 2020 | $3,099,031 |
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.